N,N-Dinitroso Ritlecitinib - Request Quote
N,N-Dinitroso Ritlecitinib
| SZ CAT No: | SZ-R088046 |
| CAS No | NA |
| Mol.F. | C15H17N7O3 |
| Mol.Wt. | 343.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
N,N-Dinitroso Ritlecitinib is chemically N-((3R,6S)-1-Acryloyl-6-methylpiperidin-3-yl)-N-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide. N,N-Dinitroso Ritlecitinib is supplied with detailed characterization data compliant with regulatory guideline. N,N-Dinitroso Ritlecitinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ritlecitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality N,N-Dinitroso Ritlecitinib
Purchase N,N-Dinitroso Ritlecitinib
N,N-Dinitroso Ritlecitinib suppliers
N,N-Dinitroso Ritlecitinib manufacturers
N,N-Dinitroso Ritlecitinib price
Order N,N-Dinitroso Ritlecitinib
Enquire N,N-Dinitroso Ritlecitinib
N,N-Dinitroso Ritlecitinib cost
N,N-Dinitroso Ritlecitinib Supplier
N,N-Dinitroso Ritlecitinib Distributor
N,N-Dinitroso Ritlecitinib for Method Validation
Ritlecitinib Reference Standard
N,N-Dinitroso Ritlecitinib for ANDA Filing
N,N-Dinitroso Ritlecitinib for Forced Degradation Studies
N,N-Dinitroso Ritlecitinib Identification Standards
N,N-Dinitroso Ritlecitinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


